Company
Hillstar Bio
Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases
Also known as Hillstar Bio, Inc.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- Hillstar Bio, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Hillstar Bio is ushering in a new era in autoimmune disease treatment through precision immunology. The company selectively targets and depletes pathogenic immune cells while sparing healthy ones, offering the potential for durable relief and immune reset for patients with autoimmune conditions.
Funding snapshot
- Total raised
- $67MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Series A, $67M
Funding rounds
- Series A
- $67MCompany stated
Loading relationship preview